1. Home
  2. GTBP vs HUIZ Comparison

GTBP vs HUIZ Comparison

Compare GTBP & HUIZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.38

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

HOLD

Current Price

$1.22

Market Cap

16.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTBP
HUIZ
Founded
1965
2006
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
17.7M
16.8M
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
GTBP
HUIZ
Price
$0.38
$1.22
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$2.30
AVG Volume (30 Days)
1.3M
13.4K
Earning Date
05-15-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
3.75
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$8.58
Revenue Next Year
N/A
$6.64
P/E Ratio
N/A
$7.81
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$1.04
52 Week High
$2.29
$4.16

Technical Indicators

Market Signals
Indicator
GTBP
HUIZ
Relative Strength Index (RSI) 41.12 48.85
Support Level $0.29 $1.19
Resistance Level $0.46 $1.55
Average True Range (ATR) 0.05 0.09
MACD -0.01 0.03
Stochastic Oscillator 27.16 64.52

Price Performance

Historical Comparison
GTBP
HUIZ

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

Share on Social Networks: